ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,528 | +89533.6% | 15,050 | +0.7% | 0.08% | -9.6% |
| Q2 2023 | $429 | +11.7% | 14,950 | 0.0% | 0.09% | +16.0% |
| Q1 2023 | $384 | +42.8% | 14,950 | -5.7% | 0.08% | +32.8% |
| Q4 2022 | $269 | -99.9% | 15,850 | +1.3% | 0.06% | 0.0% |
| Q3 2022 | $261,000 | +11.1% | 15,650 | +4.7% | 0.06% | +15.1% |
| Q2 2022 | $235,000 | -38.0% | 14,950 | +6.4% | 0.05% | -27.4% |
| Q1 2022 | $379,000 | -23.9% | 14,050 | +8.5% | 0.07% | -24.0% |
| Q4 2021 | $498,000 | -21.3% | 12,950 | -2.3% | 0.10% | -19.3% |
| Q3 2021 | $633,000 | +82.9% | 13,250 | +7.5% | 0.12% | +60.8% |
| Q2 2021 | $346,000 | +24.5% | 12,325 | +79.3% | 0.07% | +23.3% |
| Q1 2021 | $278,000 | +5.7% | 6,875 | +41.3% | 0.06% | -23.1% |
| Q2 2020 | $263,000 | – | 4,866 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |